Pages that link to "Q84147862"
Jump to navigation
Jump to search
The following pages link to Prevalence, complications, and hospital charges associated with use of bone-morphogenetic proteins in spinal fusion procedures (Q84147862):
Displaying 50 items.
- Setting the equation: establishing value in spine care (Q26859015) (← links)
- Modified Mini-open Transforaminal Lumbar Interbody Fusion (Q27318188) (← links)
- A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned (Q28242411) (← links)
- Stem cells, growth factors and scaffolds in craniofacial regenerative medicine (Q28395149) (← links)
- Use of OP-1 (rhBMP-7) in posterolateral lumbar arthrodesis (Q28564040) (← links)
- Change in Off-Label Use of Bone Morphogenetic Protein in Spine Surgery and Associations with Adverse Outcome (Q28597004) (← links)
- A consensus statement regarding the utilization of BMP in spine surgery (Q28606708) (← links)
- A review of the current published spinal literature regarding bone morphogenetic protein-2: an insight into potential bias (Q28606711) (← links)
- Epidemiologic trends in the utilization, demographics, and cost of bone morphogenetic protein in spinal fusions (Q28606713) (← links)
- The controversy surrounding bone morphogenetic proteins in the spine: a review of current research (Q28650307) (← links)
- Use of bone morphogenetic protein among patients undergoing fusion for degenerative diagnoses in the United States, 2002 to 2012 (Q28651504) (← links)
- Public awareness of the bone morphogenic protein controversy: Evidence from news publications (Q28652500) (← links)
- Trends in Bone Morphogenetic Protein Usage since the U.S. Food and Drug Administration Advisory in 2008: What Happens to Physician Practices When the Food and Drug Administration Issues an Advisory? (Q28656442) (← links)
- The enhancement of bone allograft incorporation by the local delivery of the sphingosine 1-phosphate receptor targeted drug FTY720. (Q30430805) (← links)
- Use of recombinant human bone morphogenetic protein-2 as an adjunct for instrumented posterior arthrodesis in the occipital cervical region: An analysis of safety, efficacy, and dosing (Q30432348) (← links)
- Multiple-day drainage when using bone morphogenic protein for long-segment thoracolumbar fusions is associated with low rates of wound complications (Q30456014) (← links)
- MRI of transforaminal lumbar interbody fusion: imaging appearance with and without the use of human recombinant bone morphogenetic protein-2 (rhBMP-2). (Q30458321) (← links)
- Comparison of two independent systematic reviews of trials of recombinant human bone morphogenetic protein-2 (rhBMP-2): the Yale Open Data Access Medtronic Project (Q30490905) (← links)
- Patient-specific surgical outcomes assessment using population-based data analysis for risk model development (Q30585480) (← links)
- How do coverage policies influence practice patterns, safety, and cost of initial lumbar fusion surgery? A population-based comparison of workers' compensation systems (Q33579067) (← links)
- A Retrospective Analysis of Complications Associated With Bone Morphogenetic Protein 2 in Anterior Lumbar Interbody Fusion (Q33632796) (← links)
- Formulation, Delivery and Stability of Bone Morphogenetic Proteins for Effective Bone Regeneration. (Q33639409) (← links)
- Complications, revision fusions, readmissions, and utilization over a 1-year period after bone morphogenetic protein use during primary cervical spine fusions (Q33723227) (← links)
- Evaluation of a center of excellence program for spine surgery (Q33881094) (← links)
- Heparin microparticle effects on presentation and bioactivity of bone morphogenetic protein-2 (Q33887551) (← links)
- Comparison of 5766 vertebral compression fractures treated with or without kyphoplasty. (Q33898936) (← links)
- Controlled multiple growth factor delivery from bone tissue engineering scaffolds via designed affinity (Q34063540) (← links)
- Runx2 overexpression in bone marrow stromal cells accelerates bone formation in critical-sized femoral defects (Q34083291) (← links)
- Oxidized alginate hydrogels for bone morphogenetic protein-2 delivery in long bone defects. (Q34160953) (← links)
- Conflict of interest in spine research reporting (Q34406597) (← links)
- Coating with a modular bone morphogenetic peptide promotes healing of a bone-implant gap in an ovine model (Q34491367) (← links)
- Perioperative complications with rhBMP-2 in transforaminal lumbar interbody fusion (Q34729247) (← links)
- Enhanced osteogenesis of adipose derived stem cells with Noggin suppression and delivery of BMP-2. (Q34973873) (← links)
- Hydrogel microsphere encapsulation of a cell-based gene therapy system increases cell survival of injected cells, transgene expression, and bone volume in a model of heterotopic ossification (Q35059861) (← links)
- Outcomes for single-level lumbar fusion: the role of bone morphogenetic protein (Q35100092) (← links)
- Spatiotemporal delivery of bone morphogenetic protein enhances functional repair of segmental bone defects. (Q35126888) (← links)
- Nonintegrating knockdown and customized scaffold design enhances human adipose-derived stem cells in skeletal repair. (Q35186396) (← links)
- Safety and efficacy of rhBMP2 in posterior cervical spinal fusion for subaxial degenerative spine disease: Analysis of outcomes in 204 patients (Q35183939) (← links)
- Cost-utility analysis of posterior minimally invasive fusion compared with conventional open fusion for lumbar spondylolisthesis (Q35194280) (← links)
- Bone grafting options for lumbar spine surgery: a review examining clinical efficacy and complications (Q35194313) (← links)
- How does the pathophysiological context influence delivery of bone growth factors? (Q35463054) (← links)
- Impact of total disc arthroplasty on the surgical management of lumbar degenerative disc disease: Analysis of the Nationwide Inpatient Sample from 2000 to 2008 (Q35493051) (← links)
- Controllable mineral coatings on PCL scaffolds as carriers for growth factor release (Q35534325) (← links)
- Synthetic scaffold coating with adeno-associated virus encoding BMP2 to promote endogenous bone repair (Q35566754) (← links)
- Scaffold translation: barriers between concept and clinic (Q35570019) (← links)
- Enhancement of human adipose-derived stromal cell angiogenesis through knockdown of a BMP-2 inhibitor (Q35634057) (← links)
- Injectable Peptide Decorated Functional Nanofibrous Hollow Microspheres to Direct Stem Cell Differentiation and Tissue Regeneration (Q35695114) (← links)
- Does Patient Sex Affect the Rate of Mortality and Complications After Spine Surgery? A Systematic Review. (Q35807385) (← links)
- Delivery of Phenamil Enhances BMP-2-Induced Osteogenic Differentiation of Adipose-Derived Stem Cells and Bone Formation in Calvarial Defects. (Q35865348) (← links)
- Dual Delivery of EPO and BMP2 from a Novel Modular Poly-ɛ-Caprolactone Construct to Increase the Bone Formation in Prefabricated Bone Flaps (Q36006827) (← links)